Charles River Laboratories

From early-stage research to safety assessment, your expertise can guide critical decisions in #drugdevelopment. This is your moment. https://okt.to/3XWBhG

New alternative methods (NAMs) are gaining momentum as researchers seek ways to reduce the need for research models, but are they viable solutions to advance #drugdiscovery and #drugdevelopment? Find out from our expert in this latest edition of the Sounds of Science #podcast. Listen and subscribe: https://okt.to/gxKpb4

This recent #EurekaBlog post explores emerging trends and innovations shaping the future of #oncology research. From advancements in precision medicine to novel therapeutic approaches, these developments offer hope and new possibilities for patients and researchers alike. Read more about the key topics driving progress here: https://okt.to/aKYiet

Deinococcus radiodurans, famously known as “Conan the Bacterium,” can withstand extreme conditions that would obliterate most life forms. But how does it manage this incredible feat? Our latest #Eurekablog dives into the unique DNA repair mechanisms and resilience factors that make this microorganism so extraordinary. Curious about the intersection of #biology and #innovation? This blog is for you. https://okt.to/hpi7bj

Nicola Swift Reid Reid provides valuable insights into the potential impact of USP Chapter <86> in a recent video by Pharmaceutical Technology. The discussion highlights key updates to endotoxin testing practices and their implications for standardization and safety in pharmaceutical manufacturing. Read the full article here: https://okt.to/HPufFb

Preclinical research is evolving, and leaders like Laura Lotfi are driving change. Featured in Pharma Manufacturing, Lotfi highlights how virtual control groups are transforming #drugdevelopment by improving efficiency and reducing reliance on traditional animal testing. Read the full article to learn how this approach is shaping the future of preclinical studies: https://okt.to/BSc0Z6

Collaboration is at the heart of groundbreaking discoveries. In our latest #EurekaBlog post, we explore how Charles River and Chiesi Farmaceutici are working together using scaffold hopping, a tool that is becoming popular in #drugdiscovery to expedite the discovery of new compounds. https://okt.to/J4IjAs

Join Matthew Hewitt and industry experts at the JP Morgan Healthcare Conference in San Francisco on January 15 for a panel discussion hosted by McKinsey & Company on the evolution of gene therapy, with a focus on delivery technologies and approaches to overcome existing challenges. Register by December 20: https://okt.to/wUXZWO

Artificial Intelligence is transforming #drugdiscovery, and protein structure prediction is leading the way. From faster times to new therapeutic possibilities, this technology is reshaping R&D. Discover the latest breakthroughs in our latest What's Hot in 2025 #EurekaBlog post: https://okt.to/O4f2gZ

AMAP will lead Charles River's future investments in innovative ways. Our strategic partnerships and investments will boost our capacity to deliver on alternatives using cutting-edge technologies and solutions. https://okt.to/YVoZE0